Literature DB >> 23164063

Deficits in social perception in opioid maintenance patients, abstinent opioid users and non-opioid users.

Skye McDonald1, Shane Darke, Sharlene Kaye, Michelle Torok.   

Abstract

AIMS: This study aimed to compare emotion perception and social inference in opioid maintenance patients with abstinent ex-users and non-heroin-using controls, and determine whether any deficits in could be accounted for by cognitive deficits and/or risk factors for brain damage.
DESIGN: Case-control.
SETTING: Sydney, Australia. PARTICIPANTS: A total of 125 maintenance patients (MAIN), 50 abstinent opiate users (ABST) and 50 matched controls (CON). MEASUREMENTS: The Awareness of Social Inference Test (TASIT) was used to measure emotion perception and social inference. Measures were also taken of executive function, working memory, information processing speed, verbal/non-verbal learning and psychological distress.
FINDINGS: After adjusting for age, sex, pre-morbid IQ and psychological distress, the MAIN group was impaired relative to CON (β = -0.19, P < 0.05) and ABST (β = -0.19, P < 0.05) on emotion perception and relative to CON (β = -0.25, P < 0.001) and ABST (β = -0.24, P < 0.01) on social inference. In neither case did the CON and ABST groups differ. For both emotion perception (P < 0.001) and social inference (P < 0.001), pre-morbid IQ was a significant independent predictor. Cognitive function was a major predictor of poor emotion perception (β = -0.44, P < 0.001) and social inference (β = -0.48, P < 0.001). Poor emotion recognition was also predicted by number of heroin overdoses (β = -0.14, P < 0.05). Neither time in treatment or type of maintenance medication (methadone or buprenorphine) were related to performance.
CONCLUSIONS: People in opioid maintenance treatment may have an impaired capacity for emotion perception and ability to make inferences about social situations.
© 2012 The Authors, Addiction © 2012 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23164063     DOI: 10.1111/add.12040

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  11 in total

1.  Emotion recognition and its relation to prefrontal function and network in heroin plus nicotine dependence: a pilot study.

Authors:  Hada Fong-Ha Ieong; Zhen Yuan
Journal:  Neurophotonics       Date:  2018-06-09       Impact factor: 3.593

2.  Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.

Authors:  Sara L Kroll; Emilija Nikolic; Franziska Bieri; Michael Soyka; Markus R Baumgartner; Boris B Quednow
Journal:  Psychopharmacology (Berl)       Date:  2018-10-11       Impact factor: 4.530

Review 3.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

Review 4.  Opioid system and human emotions.

Authors:  Lauri Nummenmaa; Lauri Tuominen
Journal:  Br J Pharmacol       Date:  2017-05-24       Impact factor: 8.739

5.  Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol.

Authors:  Jérôme A J Becker; Brigitte L Kieffer; Julie Le Merrer
Journal:  Addict Biol       Date:  2016-04-28       Impact factor: 4.280

6.  Facilitating mGluR4 activity reverses the long-term deleterious consequences of chronic morphine exposure in male mice.

Authors:  Jerome A J Becker; Lucie P Pellissier; Yannick Corde; Thibaut Laboute; Audrey Léauté; Jorge Gandía; Julie Le Merrer
Journal:  Neuropsychopharmacology       Date:  2020-12-21       Impact factor: 8.294

7.  Aberrant Early in Life Stimulation of the Stress-Response System Affects Emotional Contagion and Oxytocin Regulation in Adult Male Mice.

Authors:  Giovanni Laviola; Ludovica Maria Busdraghi; Noemi Meschino; Carla Petrella; Marco Fiore
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

Review 8.  Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?

Authors:  Kenneth Blum; Marcelo Febo; Panayotis K Thanos; David Baron; James Fratantonio; Mark Gold
Journal:  Mol Neurobiol       Date:  2015-03-10       Impact factor: 5.590

9.  Cognitive control in opioid dependence and methadone maintenance treatment.

Authors:  Ding-Lieh Liao; Cheng-Yi Huang; Sien Hu; Su-Chen Fang; Chi-Shin Wu; Wei-Ti Chen; Tony Szu-Hsien Lee; Pau-Chung Chen; Chiang-Shan R Li
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

Review 10.  Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review.

Authors:  Erin L Winstanley; James J Mahoney; Felipe Castillo; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2021-06-24       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.